Comment on: Boden et al. (2007) combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: Prevention of fluid retention: Diabetes 56:248-255 [1]

Research output: Contribution to journalLetter

Fingerprint Dive into the research topics of 'Comment on: Boden et al. (2007) combined use of rosiglitazone and fenofibrate in patients with type 2 diabetes: Prevention of fluid retention: Diabetes 56:248-255 [1]'. Together they form a unique fingerprint.